Package 72603-272-02

{"route": ["ORAL"], "spl_id": "35ccef4e-f4b4-80c6-e063-6394a90ae254", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0372603272017"], "unii": ["VZI5B1W380"], "rxcui": ["312137", "312138"], "spl_set_id": ["20d826cd-fa4a-4570-9e10-9d7d10fb725b"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["NorthStar RxLLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (72603-272-01)", "package_ndc": "72603-272-01", "marketing_start_date": "20240901"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (72603-272-02)", "package_ndc": "72603-272-02", "marketing_start_date": "20250428"}], "brand_name": "OXCARBAZEPINE", "product_id": "72603-272_35ccef4e-f4b4-80c6-e063-6394a90ae254", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "72603-272", "generic_name": "OXCARBAZEPINE", "labeler_name": "NorthStar RxLLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXCARBAZEPINE", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "600 mg/1"}], "application_number": "ANDA215939", "marketing_category": "ANDA", "marketing_start_date": "20240901", "listing_expiration_date": "20261231"}